Biogen and Columbia Collaborate on Genetics Research: IPF, ALS, CF, and Other Diseases with Unmet Clinical Needs
News
Cambridge, Massachusetts-based global biotechnology company, Biogen Idec, known for its dedication to finding solutions to neurodegenerative diseases, hematologic conditions and autoimmune disorders, has signed a strategic partnership agreement with Columbia University ... Read more